The vaccine industry will soon become the main source of profits for the world’s largest pharmaceutical concerns.
Technavio analysts predict that the global vaccine market for humans will increase in CAGR (cumulative annual growth rate) by 7.73% in 2018-2022, and the pharmaceutical corporations that produce vaccines will receive collectively 61 billion dollars in profit by 2020.
How do vaccines work?
Vaccines help to develop and strengthen the body’s immune system; in order for it, to put up a natural fight against serious infections and diseases, prevent epidemics and promote the health of patients – say the doctors and the pharmaceutical industry.
However, no one will officially admit that vaccines are pure business, which brings profits, not only from the sale of vaccines but also from the whole vaccination practice and from the subsequent struggle of patients with many adverse reactions caused by vaccines.
These adverse reactions are often- of course- “healed” with magic pills, which often must be administered for the rest of the life.
It is no wonder that the profits from the sale of vaccines are increasing year by year.
The increase in the number of leading vaccine manufacturers in the world is fueled by a global economic recovery. This led to a higher level of cash at the government’s disposal and through numerous propaganda campaigns, e.g. convincing that at any moment, if you do not get vaccinated – you will become ill and an epidemic will break out around you.
Profits in Billions
With the flourishing propaganda for vaccination, it is expected that the demand for different types of vaccines will grow and thus the income of the world’s 10 largest vaccine manufacturers will increase.
And the profits are not small at all!
The list of pharmaceutical companies’ income -from only vaccines- for 2012 was as follows:
- Sanofi more than $5.5 billion;
- Merck almost $5.3 billion;
- GSK almost $5,3 billion;
- Pfizer more than $4 billion;
- Novartis almost $1.4 billion.
This is how dramatically these profits are increasing from year to year, you can see by browsing the latest reports and analysts’ data. The largest financial jump of the vaccine industry was observed in 2017. Despite the failures associated with the Dengvaxia vaccine scandal, Sanofi vaccine sales increased by 8.3% to $ 6.12 billion over the past few years. GSK (GlaxoSmithKline) came first and surpassed Merck, increasing the sales of its vaccines and generating almost $7 billion in revenue compared to Merck’s $6.5 billion. According to analysts, by the year 2024, GSK will reach nearly $ 11 billion in revenue from vaccine sales.
The appetite is growing
The appetite is growing and pharmaceutical concerns do not stop at the profits derived from the sale of the vaccines alone. The pharmaceutical industry has unimaginably large sums of money. It invests, among others, in the control of research and data, imposes its standards on organizations such as WHO or SANEPID, corrupts doctors, politicians, pays for media spots, news, etc.
Having such an army under control, pharmaceutical companies impose their methods of treatment on ordinary citizens and criticize the alternative approach to health, because the latter doesn’t bring the business.
But “treating” the side effects of vaccinations – yes, THAT brings huge profits!
Here is the estimated total annual revenue from the sale of medicines and vaccines in 2017 among, currently, the 5 largest pharmaceutical concerns in the world:
- GlaxoSmithKline – more than $35 billion;
- Merck & Co –around $40 billion;
- Sanofi – more than $40 billion;
- Pfizer – around $50 billion;
- Novavax – more than $22 billion;
These numbers are not small, and the manufacturers are focused on a huge increase in profits from the sale of vaccines over the next few years.
Will they succeed?
It all depends on us if we let ourselves be drawn into this maze of lies and manipulation …